Richard Cappetta, President and CEO of MicroVention, Inc., said: "The HEAT trial is intended to provide evidence that our second-generation hydrogel coil technologies provide superior long-term ...
Please provide your email address to receive an email when new articles are posted on . Patients with intracranial aneurysms who underwent embolization with second-generation hydrogel-coated coils ...
MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...
MicroVention Inc., an Aliso Viejo-based startup medical device maker, has nabbed $10 million in an extension of its fourth round of venture funding. The new investment brings MicroVention’s total ...
US-based neuroendovascular device company MicroVention has announced a court settlement against three former members of staff accused of misappropriating trade secrets about the company’s embolic ...
The Global Neuroendovascular Coil Market is expected to grow at 5.2% CAGR from 2025 to 2032. The Latest detailed study on the global Neuroendovascular Coil Market 2025-2032, Outlook is performed by ...
MicroVention Inc., Orange County’s sixth-largest medical device maker with about 1,150 local workers, has expansion plans in its hometown of Aliso Viejo, with a sizeable new lease recently signed just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback